Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29608 | 183 | 23.8 | 43% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 213 | 3 | BURNS//CRITICAL CARE MEDICINE//SEPSIS | 51408 |
| 3412 | 2 | PENTOXIFYLLINE//PROPENTOFYLLINE//BUFLOMEDIL | 1593 |
| 29608 | 1 | BUFLOMEDIL//PYRROLIDINES THERAPEUTIC USE//CAS 55837 25 7 | 183 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | BUFLOMEDIL | authKW | 2819923 | 14% | 65% | 26 |
| 2 | PYRROLIDINES THERAPEUTIC USE | authKW | 500581 | 2% | 100% | 3 |
| 3 | CAS 55837 25 7 | authKW | 333721 | 1% | 100% | 2 |
| 4 | CENTROPHENOXINE HYDROCHLORIDE | authKW | 333721 | 1% | 100% | 2 |
| 5 | BUFLOMEDIL POSTISCHEMIC CEREBRAL DAMAGE PROTECTIVE EFFECT RAT | authKW | 166860 | 1% | 100% | 1 |
| 6 | BUFLOMEDIL PYRIDOXAL PHOSPHATE CLINICAL PHARMACOKINETICS | authKW | 166860 | 1% | 100% | 1 |
| 7 | EARLY REOCCLUSION | authKW | 166860 | 1% | 100% | 1 |
| 8 | EVANGELISMOS STATE GEN HOSP | address | 166860 | 1% | 100% | 1 |
| 9 | EXTRELUT EXTRACTION | authKW | 166860 | 1% | 100% | 1 |
| 10 | FONZYLANER CLEARANCE CLINICAL PHARMACOKINETICS | authKW | 166860 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Peripheral Vascular Diseases | 1142 | 23% | 0% | 43 |
| 2 | Pharmacology & Pharmacy | 482 | 31% | 0% | 57 |
| 3 | Medicine, General & Internal | 245 | 18% | 0% | 33 |
| 4 | Medicine, Research & Experimental | 116 | 10% | 0% | 19 |
| 5 | Toxicology | 27 | 4% | 0% | 8 |
| 6 | Hematology | 25 | 4% | 0% | 8 |
| 7 | Cardiac & Cardiovascular System | 20 | 5% | 0% | 10 |
| 8 | Chemistry, Medicinal | 19 | 4% | 0% | 7 |
| 9 | Medicine, Legal | 16 | 1% | 0% | 2 |
| 10 | Chemistry, Analytical | 11 | 5% | 0% | 9 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EVANGELISMOS STATE GEN HOSP | 166860 | 1% | 100% | 1 |
| 2 | GEORGIOS GENNIMATAS HOSP | 166860 | 1% | 100% | 1 |
| 3 | UNIT CLIN HEMORHEOL MICROCIRCULAT | 166860 | 1% | 100% | 1 |
| 4 | MECH ENG MECH | 55619 | 1% | 33% | 1 |
| 5 | HEMATOL TOXICOL | 41714 | 1% | 25% | 1 |
| 6 | HEYMANS CLIN PHARMACOL | 23835 | 1% | 14% | 1 |
| 7 | EA 3736 | 13903 | 1% | 8% | 1 |
| 8 | CLIN MAXILLO IAL PLAST SURG | 9268 | 1% | 6% | 1 |
| 9 | ADC T | 8780 | 1% | 5% | 1 |
| 10 | ANALYT ELE OCHEM UNIT | 7583 | 1% | 5% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | INVESTIGACION MEDICA INTERNACIONAL | 29990 | 2% | 4% | 4 |
| 2 | VASA-JOURNAL OF VASCULAR DISEASES | 12622 | 7% | 1% | 12 |
| 3 | ANGIOLOGY | 9336 | 9% | 0% | 16 |
| 4 | BLOOD VESSELS | 6650 | 2% | 1% | 4 |
| 5 | PHILIPPINE JOURNAL OF INTERNAL MEDICINE | 5054 | 1% | 3% | 1 |
| 6 | JOURNAL OF INTERNATIONAL MEDICAL RESEARCH | 4439 | 5% | 0% | 10 |
| 7 | CLINICAL TRIALS JOURNAL | 4224 | 2% | 1% | 3 |
| 8 | PRENSA MEDICA ARGENTINA | 3767 | 1% | 1% | 2 |
| 9 | INTERNATIONAL JOURNAL OF MICROCIRCULATION-CLINICAL AND EXPERIMENTAL | 3162 | 2% | 1% | 3 |
| 10 | VESTNIK ROSSIISKOI AKADEMII MEDITSINSKIKH NAUK | 2266 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | CLISSOLD, SP , LYNCH, S , SORKIN, EM , (1987) BUFLOMEDIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY IN PERIPHERAL AND CEREBRAL VASCULAR DISEASES.DRUGS. VOL. 33. ISSUE 5. P. 430-460 | 49 | 88% | 76 |
| 2 | BUCOLO, C , LONGO, L , CAMILLIERI, G , DRAGO, F , SALOMONE, S , (2012) SAFETY PROFILE ASSESSMENT OF BUFLOMEDIL: AN OVERVIEW OF ADVERSE REACTIONS BETWEEN 1975 AND 2011.PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. VOL. 21. ISSUE 11. P. 1190-1196 | 14 | 93% | 1 |
| 3 | TSENG, CH , TAI, TY , WU, HP , CHUANG, LM , LIN, BJ , (1992) THE EFFECT OF ORAL BUFLOMEDIL ON MICROALBUMINURIA IN NON-INSULIN-DEPENDENT DIABETIC-PATIENTS.DIABETES RESEARCH AND CLINICAL PRACTICE. VOL. 16. ISSUE 2. P. 117-122 | 20 | 91% | 2 |
| 4 | FORFAR-BARES, I , PEHOURCQ, F , JARRY, C , (2002) RAPID HPLC MEASUREMENT OF BUFLOMEDIL IN PLASMA IN POISONING CASES.BIOMEDICAL CHROMATOGRAPHY. VOL. 16. ISSUE 7. P. 482-485 | 11 | 92% | 3 |
| 5 | DE BACKER, TLM , VANDER STICHELE, RH , VAN BORTEL, LM , (2009) BIAS IN BENEFIT-RISK APPRAISAL IN OLDER PRODUCTS THE CASE OF BUFLOMEDIL FOR INTERMITTENT CLAUDICATION.DRUG SAFETY. VOL. 32. ISSUE 4. P. 283-291 | 11 | 69% | 4 |
| 6 | FORT, FL , RUCKMAN, SA , GREGSON, RL , PATTERSON, DR , (1993) BUFLOMEDIL - ONE-YEAR ORAL SAFETY EVALUATION IN RATS.DRUG AND CHEMICAL TOXICOLOGY. VOL. 16. ISSUE 2. P. 195-205 | 16 | 80% | 1 |
| 7 | REN, L , YANG, C , PENG, Y , LI, F , LI, YH , ZHENG, H , (2013) APPLICATION OF A HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY METHOD FOR DETERMINATION OF BUFLOMEDIL IN HUMAN PLASMA FOR A BIOEQUIVALENCE STUDY.JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES. VOL. 935. ISSUE . P. 41-46 | 6 | 100% | 1 |
| 8 | EL-DESOKY, HS , GHONEIM, MM , ABDEL-GALEIL, MM , (2010) QUANTIFICATION OF THE VASOACTIVE AGENT BUFLOMEDIL HCL IN PHARMACEUTICAL FORMULATION AND HUMAN SERUM BY STRIPPING VOLTAMMETRY AND LIQUID CHROMATOGRAPHY.ACTA CHIMICA SLOVENICA. VOL. 57. ISSUE 2. P. 332-340 | 9 | 69% | 1 |
| 9 | DE BACKER, TLM , STICHELE, RV , (2013) BUFLOMEDIL FOR INTERMITTENT CLAUDICATION.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 3. P. - | 8 | 62% | 1 |
| 10 | TRACQUI, A , DEVEAUX, M , KINTZ, P , MANGIN, P , GOSSET, D , (1995) A FATAL CASE OF BUFLOMEDIL SELF-POISONING - TOXICOLOGICAL DATA AND LITERATURE-REVIEW.FORENSIC SCIENCE INTERNATIONAL. VOL. 71. ISSUE 1. P. 43-49 | 10 | 77% | 10 |
Classes with closest relation at Level 1 |